SpringerLink (Online service) & Trifilieff, A. (2014). Indacaterol: The first once-daily long-acting Beta2 Agonist for COPD. Springer Basel.
Chicago Style (17th ed.) CitationSpringerLink (Online service) and Alexandre Trifilieff. Indacaterol: The First Once-daily Long-acting Beta2 Agonist for COPD. Basel: Springer Basel, 2014.
MLA (8th ed.) CitationSpringerLink (Online service) and Alexandre Trifilieff. Indacaterol: The First Once-daily Long-acting Beta2 Agonist for COPD. Springer Basel, 2014.
Warning: These citations may not always be 100% accurate.